Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1745-6215
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial ; volume:21 ; number:1 ; day:27 ; month:10 ; year:2020 ; pages:1-12 ; date:12.2020
Trials ; 21, Heft 1 (27.10.2020), 1-12, 12.2020

Creator
Acharya, Nisha R.
Ebert, Caleb D.
Kelly, Nicole K.
Porco, Travis C.
Ramanan, Athimalaipet V.
Arnold, Benjamin F.
Contributor
SpringerLink (Online service)

DOI
10.1186/s13063-020-04796-z
URN
urn:nbn:de:101:1-2020121118582767670520
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Acharya, Nisha R.
  • Ebert, Caleb D.
  • Kelly, Nicole K.
  • Porco, Travis C.
  • Ramanan, Athimalaipet V.
  • Arnold, Benjamin F.
  • SpringerLink (Online service)

Other Objects (12)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab

Juvenile idiopathic arthritis-associated uveitis

Juvenile idiopathic arthritis-associated uveitis

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases

Perinatal events and development of juvenile idiopathic arthritis-associated uveitis

Perinatal events and development of juvenile idiopathic arthritis-associated uveitis

Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis

Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis

Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient

Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient

Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice

Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice

Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab

Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab

Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab

Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab

Haptoglobin in Juvenile Idiopathic Arthritis

Haptoglobin in Juvenile Idiopathic Arthritis

Ultrasound in juvenile idiopathic arthritis

Ultrasound in juvenile idiopathic arthritis

Related objects